Genomictree Inc. (228760.KQ)
KRW 23550.0
(3.06%)
KRW 23550.0
(3.06%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -43.43 Billion KRW | -13.14% |
| 2022 | -38.39 Billion KRW | -37.03% |
| 2021 | -28.01 Billion KRW | 37.87% |
| 2020 | -45.09 Billion KRW | -8.14% |
| 2019 | -41.69 Billion KRW | -542.18% |
| 2018 | -6.49 Billion KRW | -90.39% |
| 2017 | -3.41 Billion KRW | -304.02% |
| 2016 | -844.14 Million KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -21.12 Billion KRW | 46.23% |
| 2024 Q1 | -39.29 Billion KRW | 9.53% |
| 2023 Q4 | -43.43 Billion KRW | 25.15% |
| 2023 Q3 | -58.03 Billion KRW | 16.82% |
| 2023 Q2 | -69.76 Billion KRW | -85.26% |
| 2023 Q1 | -37.65 Billion KRW | 1.91% |
| 2023 FY | -43.43 Billion KRW | -13.14% |
| 2022 Q4 | -38.39 Billion KRW | -105.46% |
| 2022 Q2 | -13.88 Billion KRW | 39.27% |
| 2022 Q1 | -22.85 Billion KRW | 18.41% |
| 2022 Q3 | -18.68 Billion KRW | -34.59% |
| 2021 Q4 | -28.01 Billion KRW | -14598.87% |
| 2021 Q3 | 193.23 Million KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HLB Co., Ltd. | -46.18 Billion KRW | 5.951% |
| iNtRON Biotechnology, Inc. | -40.58 Billion KRW | -7.023% |
| BINEX Co., Ltd. | 45.34 Billion KRW | 195.783% |
| Bioneer Corporation | -3.9 Billion KRW | -1011.501% |
| Anterogen.Co.,Ltd. | 8.35 Billion KRW | 620.07% |
| MEDIPOST Co., Ltd. | 14.81 Billion KRW | 393.197% |
| CrystalGenomics, Inc. | 8.99 Billion USD | 583.047% |
| Helixmith Co., Ltd | -24.42 Billion KRW | -77.825% |
| Chabiotech Co.,Ltd. | 388.94 Billion KRW | 111.167% |
| Medy-Tox Inc. | 49.58 Billion KRW | 187.599% |
| Peptron, Inc. | 4.86 Billion KRW | 992.143% |
| Amicogen, Inc. | 125.26 Billion KRW | 134.675% |
| Genexine, Inc. | 61.39 Billion KRW | 170.746% |
| HLB Therapeutics Co.,Ltd. | -13.68 Billion KRW | -217.351% |
| LegoChem Biosciences, Inc. | -56.05 Billion KRW | 22.511% |
| ALTEOGEN Inc. | 53.56 Billion KRW | 181.081% |
| PharmaResearch Co., Ltd. | -32.93 Billion KRW | -31.868% |
| SillaJen, Inc. | -13.89 Billion KRW | -212.672% |
| JETEMA, Co., Ltd. | 84.27 Billion KRW | 151.537% |
| OliX Pharmaceuticals,Inc | 27.37 Billion KRW | 258.668% |
| MedPacto, Inc. | -64 Billion KRW | 32.133% |
| D&D Pharmatech | -7.5 Billion KRW | -478.533% |
| EASY BIO,Inc. | 53.21 Billion KRW | 181.629% |
| GI Innovation, Inc. | -4.82 Billion KRW | -800.675% |